Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2019-2025

2019-01-14 / 3900.00 / Pharma & Healthcare / 91 Pages

Description

Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose any symptom but in severe cases it can cause pain during urination and can cause problem during sexual intercourse. Castration resistant prostate cancer is referred to as a prostate cancer that is spread to other parts of body and is resistant to medical or surgical treatment. Risk factor for castration resistant prostate cancer includes genetic predisposition, geriatric population, unhygienic diet, medication exposure and many sexual partners. Diagnosis for the detection of castration resistant prostate cancer includes prostate imaging, biopsy, tumor marker and staging test. Crucial factor about castration resistant prostate cancer is that it is resistant to medical and surgical treatment.  However, other treatment options that are available in the market include hormone therapy, immune modulation, antiangiogenic treatment and bone targeted therapies.
North America dominates the global market for castration resistant prostate cancer treatment due to presence of large prostate cancer population in this region. Moreover, increasing demand of diagnostic test, increasing awareness among people and initiative taken by the federal government also accounted for the market growth in North American region. Europe represents the second position in the global castration resistant prostate cancer treatment market due to presence of large geriatric population base in European region. Asia-Pacific is considered as an untapped market due to lack of awareness and lack of proper healthcare facilities in some Asian countries. Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in the healthcare infrastructure (healthcare cost, healthcare facility and healthcare budget). Similarly, Asia-Pacific is considered as an emerging market during the study period due to growing market penetration in this region.
In 2018, the global Castration Resistant Prostate Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Castration Resistant Prostate Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Castration Resistant Prostate Cancer Treatment development in United States, Europe and China.

The key players covered in this study
Active Biotech
Diagnocure
Glaxosmithkline
Northwest Biotherapeutics
Millennium Pharmaceuticals
Hologic
Spectrum Pharmaceuticals
Abbott Laboratories
Bayer Healthcare Pharmaceuticals

Market segment by Type, the product can be split into
Hormonal Therapy
Adding An Anti-Androgen
Stopping An Anti-Androgen
Estrogens
Chemotherapy
Radiation Therapy
Others

Market segment by Application, split into
Hospital
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Castration Resistant Prostate Cancer Treatment status, future forecast, growth opportunity, key market and key players.
To present the Castration Resistant Prostate Cancer Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Castration Resistant Prostate Cancer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Hormonal Therapy
1.4.3 Adding An Anti-Androgen
1.4.4 Stopping An Anti-Androgen
1.4.5 Estrogens
1.4.6 Chemotherapy
1.4.7 Radiation Therapy
1.4.8 Others
1.5 Market by Application
1.5.1 Global Castration Resistant Prostate Cancer Treatment Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Castration Resistant Prostate Cancer Treatment Market Size
2.2 Castration Resistant Prostate Cancer Treatment Growth Trends by Regions
2.2.1 Castration Resistant Prostate Cancer Treatment Market Size by Regions (2014-2025)
2.2.2 Castration Resistant Prostate Cancer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Castration Resistant Prostate Cancer Treatment Market Size by Manufacturers
3.1.1 Global Castration Resistant Prostate Cancer Treatment Revenue by Manufacturers (2014-2018)
3.1.2 Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Manufacturers (2014-2018)
3.1.3 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Castration Resistant Prostate Cancer Treatment Key Players Head office and Area Served
3.3 Key Players Castration Resistant Prostate Cancer Treatment Product/Solution/Service
3.4 Date of Enter into Castration Resistant Prostate Cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2014-2019)
4.2 Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
5.2 Castration Resistant Prostate Cancer Treatment Key Players in United States
5.3 United States Castration Resistant Prostate Cancer Treatment Market Size by Type
5.4 United States Castration Resistant Prostate Cancer Treatment Market Size by Application

6 Europe
6.1 Europe Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
6.2 Castration Resistant Prostate Cancer Treatment Key Players in Europe
6.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type
6.4 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application

7 China
7.1 China Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
7.2 Castration Resistant Prostate Cancer Treatment Key Players in China
7.3 China Castration Resistant Prostate Cancer Treatment Market Size by Type
7.4 China Castration Resistant Prostate Cancer Treatment Market Size by Application

8 Japan
8.1 Japan Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
8.2 Castration Resistant Prostate Cancer Treatment Key Players in Japan
8.3 Japan Castration Resistant Prostate Cancer Treatment Market Size by Type
8.4 Japan Castration Resistant Prostate Cancer Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
9.2 Castration Resistant Prostate Cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size by Type
9.4 Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size by Application

10 India
10.1 India Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
10.2 Castration Resistant Prostate Cancer Treatment Key Players in India
10.3 India Castration Resistant Prostate Cancer Treatment Market Size by Type
10.4 India Castration Resistant Prostate Cancer Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Castration Resistant Prostate Cancer Treatment Market Size (2014-2019)
11.2 Castration Resistant Prostate Cancer Treatment Key Players in Central & South America
11.3 Central & South America Castration Resistant Prostate Cancer Treatment Market Size by Type
11.4 Central & South America Castration Resistant Prostate Cancer Treatment Market Size by Application

12 International Players Profiles
12.1 Active Biotech
12.1.1 Active Biotech Company Details
12.1.2 Company Description and Business Overview
12.1.3 Castration Resistant Prostate Cancer Treatment Introduction
12.1.4 Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
12.1.5 Active Biotech Recent Development
12.2 Diagnocure
12.2.1 Diagnocure Company Details
12.2.2 Company Description and Business Overview
12.2.3 Castration Resistant Prostate Cancer Treatment Introduction
12.2.4 Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
12.2.5 Diagnocure Recent Development
12.3 Glaxosmithkline
12.3.1 Glaxosmithkline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Castration Resistant Prostate Cancer Treatment Introduction
12.3.4 Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
12.3.5 Glaxosmithkline Recent Development
12.4 Northwest Biotherapeutics
12.4.1 Northwest Biotherapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Castration Resistant Prostate Cancer Treatment Introduction
12.4.4 Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
12.4.5 Northwest Biotherapeutics Recent Development
12.5 Millennium Pharmaceuticals
12.5.1 Millennium Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Castration Resistant Prostate Cancer Treatment Introduction
12.5.4 Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
12.5.5 Millennium Pharmaceuticals Recent Development
12.6 Hologic
12.6.1 Hologic Company Details
12.6.2 Company Description and Business Overview
12.6.3 Castration Resistant Prostate Cancer Treatment Introduction
12.6.4 Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
12.6.5 Hologic Recent Development
12.7 Spectrum Pharmaceuticals
12.7.1 Spectrum Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Castration Resistant Prostate Cancer Treatment Introduction
12.7.4 Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
12.7.5 Spectrum Pharmaceuticals Recent Development
12.8 Abbott Laboratories
12.8.1 Abbott Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Castration Resistant Prostate Cancer Treatment Introduction
12.8.4 Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
12.8.5 Abbott Laboratories Recent Development
12.9 Bayer Healthcare Pharmaceuticals
12.9.1 Bayer Healthcare Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Castration Resistant Prostate Cancer Treatment Introduction
12.9.4 Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
12.9.5 Bayer Healthcare Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details


Table of Figures

List of Tables and Figures

Table Castration Resistant Prostate Cancer Treatment Key Market Segments
Table Key Players Castration Resistant Prostate Cancer Treatment Covered
Table Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Castration Resistant Prostate Cancer Treatment Market Size Market Share by Type 2014-2025
Figure Hormonal Therapy Figures
Table Key Players of Hormonal Therapy
Figure Adding An Anti-Androgen Figures
Table Key Players of Adding An Anti-Androgen
Figure Stopping An Anti-Androgen Figures
Table Key Players of Stopping An Anti-Androgen
Figure Estrogens Figures
Table Key Players of Estrogens
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Others Figures
Table Key Players of Others
Table Global Castration Resistant Prostate Cancer Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Castration Resistant Prostate Cancer Treatment Report Years Considered
Table Global Castration Resistant Prostate Cancer Treatment Market Size 2014-2025 (Million US$)
Figure Global Castration Resistant Prostate Cancer Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Castration Resistant Prostate Cancer Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Castration Resistant Prostate Cancer Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Castration Resistant Prostate Cancer Treatment Market Share by Regions 2014-2019
Figure Global Castration Resistant Prostate Cancer Treatment Market Share by Regions 2014-2019
Figure Global Castration Resistant Prostate Cancer Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Castration Resistant Prostate Cancer Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Castration Resistant Prostate Cancer Treatment Market Share by Manufacturers (2014-2019)
Figure Global Castration Resistant Prostate Cancer Treatment Market Share by Manufacturers in 2018
Table Global Castration Resistant Prostate Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Castration Resistant Prostate Cancer Treatment Product/Solution/Service
Table Date of Enter into Castration Resistant Prostate Cancer Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Castration Resistant Prostate Cancer Treatment Market Size Share by Type (2014-2019)
Figure Global Castration Resistant Prostate Cancer Treatment Market Size Market Share by Type (2014-2019)
Table Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Castration Resistant Prostate Cancer Treatment Market Size Share by Application (2014-2019)
Figure Global Castration Resistant Prostate Cancer Treatment Market Size Market Share by Application (2014-2019)
Figure Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application in 2018
Figure United States Castration Resistant Prostate Cancer Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Castration Resistant Prostate Cancer Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Castration Resistant Prostate Cancer Treatment Market Share (2018-2019)
Table United States Castration Resistant Prostate Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Castration Resistant Prostate Cancer Treatment Market Share by Type (2014-2019)
Table United States Castration Resistant Prostate Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Castration Resistant Prostate Cancer Treatment Market Share by Application (2014-2019)
Figure Europe Castration Resistant Prostate Cancer Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Castration Resistant Prostate Cancer Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Castration Resistant Prostate Cancer Treatment Market Share (2018-2019)
Table Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Castration Resistant Prostate Cancer Treatment Market Share by Type (2014-2019)
Table Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Castration Resistant Prostate Cancer Treatment Market Share by Application (2014-2019)
Figure China Castration Resistant Prostate Cancer Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Castration Resistant Prostate Cancer Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Castration Resistant Prostate Cancer Treatment Market Share (2018-2019)
Table China Castration Resistant Prostate Cancer Treatment Market Size by Type (2014-20189) (Million US$)
Table China Castration Resistant Prostate Cancer Treatment Market Share by Type (2014-2019)
Table China Castration Resistant Prostate Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table China Castration Resistant Prostate Cancer Treatment Market Share by Application (2014-2019)
Figure Japan Castration Resistant Prostate Cancer Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Castration Resistant Prostate Cancer Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Castration Resistant Prostate Cancer Treatment Market Share (2018-2019)
Table Japan Castration Resistant Prostate Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Castration Resistant Prostate Cancer Treatment Market Share by Type (2014-2019)
Table Japan Castration Resistant Prostate Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Castration Resistant Prostate Cancer Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Castration Resistant Prostate Cancer Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Castration Resistant Prostate Cancer Treatment Market Share (2018-2019)
Table Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Castration Resistant Prostate Cancer Treatment Market Share by Type (2014-2019)
Table Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Castration Resistant Prostate Cancer Treatment Market Share by Application (2014-2019)
Figure India Castration Resistant Prostate Cancer Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Castration Resistant Prostate Cancer Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Castration Resistant Prostate Cancer Treatment Market Share (2018-2019)
Table India Castration Resistant Prostate Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table India Castration Resistant Prostate Cancer Treatment Market Share by Type (2014-2019)
Table India Castration Resistant Prostate Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table India Castration Resistant Prostate Cancer Treatment Market Share by Application (2014-2019)
Figure Central & South America Castration Resistant Prostate Cancer Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Castration Resistant Prostate Cancer Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Castration Resistant Prostate Cancer Treatment Market Share (2018-2019)
Table Central & South America Castration Resistant Prostate Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Castration Resistant Prostate Cancer Treatment Market Share by Type (2014-2019)
Table Central & South America Castration Resistant Prostate Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Castration Resistant Prostate Cancer Treatment Market Share by Application (2014-2019)
Table Active Biotech Company Details
Table Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019) (Million US$)
Figure Active Biotech Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
Table Active Biotech Recent Development
Table Diagnocure Company Details
Table Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)(Million US$)
Figure Diagnocure Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
Table Diagnocure Recent Development
Table Glaxosmithkline Company Details
Table Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)(Million US$)
Figure Glaxosmithkline Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
Table Glaxosmithkline Recent Development
Table Northwest Biotherapeutics Company Details
Table Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)(Million US$)
Figure Northwest Biotherapeutics Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
Table Northwest Biotherapeutics Recent Development
Table Millennium Pharmaceuticals Company Details
Table Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)(Million US$)
Figure Millennium Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
Table Millennium Pharmaceuticals Recent Development
Table Hologic Company Details
Table Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)(Million US$)
Figure Hologic Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
Table Hologic Recent Development
Table Spectrum Pharmaceuticals Company Details
Table Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)(Million US$)
Figure Spectrum Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
Table Spectrum Pharmaceuticals Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Bayer Healthcare Pharmaceuticals Company Details
Table Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2014-2019)(Million US$)
Figure Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2014-2019)
Table Bayer Healthcare Pharmaceuticals Recent Development
Table Global Castration Resistant Prostate Cancer Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Castration Resistant Prostate Cancer Treatment Market Size Share by Regions (2019-2025)
Figure Global Castration Resistant Prostate Cancer Treatment Market Size Share by Regions in 2025
Figure United States Castration Resistant Prostate Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Castration Resistant Prostate Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Castration Resistant Prostate Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Castration Resistant Prostate Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Castration Resistant Prostate Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Castration Resistant Prostate Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Castration Resistant Prostate Cancer Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Castration Resistant Prostate Cancer Treatment Market Size by Product (2019-2025)
Figure Global Castration Resistant Prostate Cancer Treatment Market Size by Product in 2025
Table Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2019-2025)
Figure Global Castration Resistant Prostate Cancer Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory